Roivant Sciences Ltd.
Roivant Sciences Ltd. (ROIV) — Form 144/A: Proposed sale of shares (amendment)
About this filing
Roivant Sciences Ltd. (ROIV) filed Form 144/A (proposed sale of shares (amendment)) with the SEC on Nov 10, 2026. Form 144 is notice that an insider or affiliate plans to sell shares.
Key facts
- Seller
- MATTHEW ADAM GLINE
- Relationship
- Officer, Director
- Shares to sell
- 164,136
- Market value
- $6,729,576.00
- Approximate sale date
- Nov 10, 2026
- Broker
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Acquired
- Nov 10, 2026 · Performance Stock Units
Remarks
- We are amending this filing to add the following remarks: The Shares covered by this Form 144 are being sold automatically pursuant to a mandatory, non-discretionary, sell-to-cover arrangement adopted by the Issuer for the purpose of satisfying tax withholding obligations incurred upon the vesting and settlement of equity awards.
More ROIV filings
- 144/A
Filed Nov 10, 2026
- 144/A
Filed Nov 10, 2026
- 144
Filed Nov 10, 2026
- 144
Filed Nov 10, 2026
- 144
Filed Nov 10, 2026
- 144
Filed Nov 10, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.